Novo CEO pressed by Senate to cut rates of obesity, diabetic issues medications CEO Lars Fruergaard Jørgensen informed lawmakers the business would think about new talks with insurers regarding the list prices of Wegovy and copyright whenever they pledge to maintain the medicines on their formularies. Never pass up tomorrow's https://kethek.com/